MeSH Browser

MeSH Heading: Medroxyprogesterone Acetate
Tree Number(s): D04.210.500.745.745.654.829.395.700.500
Unique ID: D017258
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D017258
Scope Note: A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.
Entry Term(s): (6 alpha)-17-(Acetoxy)-6-methylpregn-4-ene-3,20-dione; 6-alpha-Methyl-17alpha-hydroxyprogesterone Acetate; Curretab; Cycrin; Depo-Medroxyprogesterone Acetate; Depo-Provera; Farlutal; Gestapuran; Medroxyprogesterone 17-Acetate; Medroxyprogesterone 17-Acetate, (6 alpha,17 alpha)-Isomer; Medroxyprogesterone 17-Acetate, (6 beta)-Isomer; Perlutex; Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6alpha)-; Provera; Veramix
Pharm Action: Contraceptive Agents, Hormonal
Contraceptive Agents, Female
Contraceptive Agents, Male
Antineoplastic Agents, Hormonal
Registry Number: C2QI4IOI2G
Related Numbers: 1172-82-3; 2242-65-1; 560-12-3; 71-58-9
Previous Indexing: Hydroxyprogesterones (1976-1978); Medroxyprogesterone (1973-1975); Medroxyprogesterone/analogs & derivatives (1978-1992)
Public MeSH Note: 2010; see MEDROXYPROGESTERONE 17-ACETATE 1993-2009; MEDROXYPROGESTERONE 17-ACETATE was indexed under MEDROXYPROGESTERONE/analogs & derivatives 1978-1992, HYDROXYPROGESTERONES 1976-78, & MEDROXYPROGESTERONE 1973-75
History Note: 2010 (1973)
Date Established: 1993/01/01
Date of Entry: 1992/05/18
Revision Date: 2019/07/08

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Polycyclic Compounds [D04]
- Fused-Ring Compounds [D04.210]
  - Steroids [D04.210.500]
    - Pregnanes [D04.210.500.745]
      - Pregnenes [D04.210.500.745.745]
        
        Pregnenediones [D04.210.500.745.745.654]
        
        Progesterone [D04.210.500.745.745.654.829]
        
        Hydroxyprogesterones [D04.210.500.745.745.654.829.395]
        
        Medroxyprogesterone [D04.210.500.745.745.654.829.395.700]
        
        Medroxyprogesterone Acetate [D04.210.500.745.745.654.829.395.700.500]

Medroxyprogesterone Acetate Preferred

Concept UI: M0026185
Registry Number: C2QI4IOI2G
Related Numbers: 1172-82-3; 2242-65-1; 560-12-3; 71-58-9
Scope Note: A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.
Terms: Medroxyprogesterone Acetate Preferred Term
Term UI T051459
Date02/03/1992
LexicalTag NON
ThesaurusID; 6-alpha-Methyl-17alpha-hydroxyprogesterone Acetate
Term UI T051461
Date11/13/1996
LexicalTag NON
ThesaurusID NLM (1998); Depo-Medroxyprogesterone Acetate
Term UI T051458
Date01/08/1992
LexicalTag NON
ThesaurusID NLM (1993); (6 alpha)-17-(Acetoxy)-6-methylpregn-4-ene-3,20-dione
Term UI T051460
Date11/13/1996
LexicalTag NON
ThesaurusID NLM (1998); Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6alpha)-
Term UI T000963282
Date07/08/2019
LexicalTag NON
ThesaurusID NLM (2020); Medroxyprogesterone 17-Acetate
Term UI T051457
Date01/01/1999
LexicalTag NON
ThesaurusID NLM (1993)

Depo-Provera Narrower

Farlutal Narrower

Gestapuran Narrower

Curretab Narrower

Medroxyprogesterone 17-Acetate, (6 beta)-Isomer Related

Perlutex Narrower

Provera Narrower

Veramix Narrower

Cycrin Narrower

Medroxyprogesterone 17-Acetate, (6 alpha,17 alpha)-Isomer Narrower

Medroxyprogesterone Acetate MeSH Descriptor Data 2023